Strata Critical MedicalSRTA -1.21%70 Gross Margin % is 20.95% as of Mar. 2026, which is 12% above its 10-year median of 18.71. GuruFocus rates SRTA with a GF Score™ of 70/100 and a GF Value™ of $4.47 (Modestly Overvalued). The stock has 4 warning signs investors should review. Among 631 Healthcare Providers & Services companies, Strata Critical Medical ranks worse than 81.62% on this metric.
SRTA's Gross Margin % is ranked worse than 81.62% of 631
companies
in the Healthcare Providers & Services industry
Industry Median: 40.09
vs SRTA: 21.69
Strata Critical Medical had a gross margin of 20.95% for the quarter that ended in Mar. 2026 => Competition eroding margins
The 5-Year average Growth Rate of Gross Margin for Strata Critical Medical was 11.50% per year.
Strata Critical Medical (NAS:SRTA) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Strata Critical Medical had a gross margin of 20.95% for the quarter that ended in Mar. 2026 => Competition eroding margins
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Strata Critical Medical Gross Margin % Related Terms
Strata Critical Medical Gross Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SRTA vs TOI, GMRS, CCRN: Gross Margin % Comparison
For the Medical Care Facilities subindustry, Strata Critical Medical's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Strata Critical Medical Gross Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Strata Critical Medical's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Strata Critical Medical's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Strata Critical Medical (SRTA) has a Gross Margin % of 20.95% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Strata Critical Medical and its competitors. This is 12% above median its historical median of 18.71. Over the past decade, Strata Critical Medical's Gross Margin % has ranged from 9.93 to 21.69. According to the industry distribution chart, Strata Critical Medical ranks #515 out of 631 companies in the Healthcare Providers & Services industry, placing it in the top 81.6%.
Is Strata Critical Medical's Gross Margin % too high?
Strata Critical Medical's current Gross Margin % of 20.95% is 12% above median its 10-year median of 18.71. Over the past 10 years, this metric has ranged from a low of 9.93 to a high of 21.69. The Healthcare Providers & Services industry median Gross Margin % is 40.09. Strata Critical Medical's value of 20.95% is 47.7% below this industry median. Based on the distribution chart, Strata Critical Medical ranks #515 out of 631 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Strata Critical Medical has a GF Score™ of 70/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Strata Critical Medical's Gross Margin % compare to TOI and GMRS?
According to the Healthcare Providers & Services industry distribution chart, Strata Critical Medical ranks #515 out of 631 companies for Gross Margin %. This places Strata Critical Medical in the lower half of its industry. The industry median Gross Margin % is 40.09. Strata Critical Medical's value of 20.95% is 47.7% below this benchmark. Historically, Strata Critical Medical's own Gross Margin % has ranged from 9.93 to 21.69 over the past decade. While the company's 10-year median is 18.71 vs. the industry median of 40.09, Strata Critical Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Healthcare Providers & Services company?
The median Gross Margin % among Healthcare Providers & Services companies is 40.09, based on 631 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Strata Critical Medical's current Gross Margin % of 20.95% is 47.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Strata Critical Medical and its competitors. For the Healthcare Providers & Services industry, the median Gross Margin % is 40.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Strata Critical Medical's current Gross Margin % is 20.95%, which is 12% above median its own 10-year median of 18.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Strata Critical Medical stock overvalued right now?
Based on GuruFocus' analysis, Strata Critical Medical (SRTA) is currently considered Modestly Overvalued. The stock's GF Value™ is $4.47, compared to a current price of $5.30 — trading 18.5% above its estimated fair value. The current Gross Margin % is 20.95%, which is 12% above median its 10-year median of 18.71 and 47.7% below the Healthcare Providers & Services industry median of 40.09. Strata Critical Medical's overall GF Score™ is 70/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Strata Critical Medical (SRTA), the current Gross Margin % is 20.95% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Strata Critical Medical (SRTA) Overvalued in 2026?
Based on GuruFocus' analysis, Strata Critical Medical stock appears to be overvalued.
The current stock price of $5.30 is trading 18.5% above its estimated GF Value™ of $4.47.
GuruFocus considers Strata Critical Medical to be Modestly Overvalued.
Key valuation signals for SRTA:
Gross Margin %: 20.95% (12% above median its 10-year median of 18.71)
GF Value™: $4.47 vs. price of $5.30 (18.5% above fair value)
Industry Position: 47.7% below the Healthcare Providers & Services median (#515 of 631)
No single metric tells the full story. See the SRTA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Strata Critical Medical Inc is a time-critical logistics and medical services provider to the U.S. healthcare industry. The group operates one of the nation's air transport and surgical services networks for transplant hospitals and organ procurement organizations, offering an integrated 'One Call' solution for donor organ recovery. It includes two segments: Logistics segments which hold, Air Logistics, Ground Logistics and Organ Placement. The second segment is Clinical Segment which includes: Organ Recovery, Normothermic Regional Perfusion (NRP), and Preservation, and Other Clinical Segment which has Cardiac Care, and Other.
70GF Score
Get the complete analysis for SRTA
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SRTA has been successfully added to your 
